U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Transdermal therapeutic system having improved delivery characteristics

Patent 4704282 Issued on November 3, 1987. Estimated Expiration Date: Icon_subject November 3, 2004. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

3598122

3742951

3813466

3923939

Drug-delivery device comprising certain polymeric materials for controlled release of drug
Patent #: 4069307
Issued on: 01/17/1978
Inventor: Higuchi ,   et al.

Device consisting of copolymer having acetoxy groups for delivering drugs
Patent #: 4144317
Issued on: 03/13/1979
Inventor: Higuchi ,   et al.

Therapeutic system for administering clonidine transdermally
Patent #: 4201211
Issued on: 05/06/1980
Inventor: Chandrasekaran ,   et al.

Biosynthetic polymeric compositions
Patent #: 4243656
Issued on: 01/06/1981
Inventor: Walliczek

Method and therapeutic system for administering scopolamine transdermally
Patent #: 4262003
Issued on: 04/14/1981
Inventor: Urquhart ,   et al.

Therapeutic system for administering drugs to the skin
Patent #: 4286592
Issued on: 09/01/1981
Inventor: Chandrasekaran

More ...

Inventors

Application

No. 06/626095 filed on 06/29/1984

US Classes:

424/449, Transdermal or percutaneous424/448, Pressure sensitive adhesive means514/953, SHAPED FORMS ADAPTED FOR NONINGESTIBLE USE OTHER THAN SUPPOSITORY TYPE (E.G., FILMS, INSERTS, ETC.)514/965Discrete particles in supporting matrix

Examiners

Primary: Griffin, Ronald W.

Attorney, Agent or Firm

International Class

A61K 9/70 (20060101)

Abstract

A transdermal therapeutic system using a subsaturated matrix is provided having improved approved release characteristics. Reinforcing means preferably in the form of a fabric are embedded in the upper surface of the subsaturated matrix. At least a portion of the reinforcing means is selected such that the active agent to be delivered to the skin has a solubility, Cr therein which is lower than the initial solubility Co of the agent in the matrix. In addition, the relationship between the diffusion coefficients of the agent in the matrix Dm and the portion of reinforcing means Dr and the solubilities is given by the relationship: Dr ⋅Cr <Dm ⋅Co. In operation the agent dissolved in the reinforcing means acts as a secondary reservoir improving the release characteristics of the system. Specific embodiments of the invention are particularly adapted for scrotal and labial delivery of drugs such as testosterone and progesterone.

Other References

  • Ben Galim et al., "Topically Applied Testosterone and Phallic Growth", AM. J. Dis. Child., 134:296-298 (1980)
  • Jacobs et al., Topical Testosterone Therapy for Penile Growth, UROL, 6:708-710 (1975)
  • Klugo et al., "Response of Micropenis to Topical Testosterone and Gonadotropin", J. UROL, 119:667-668 (1978)
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?